Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
07 July 2023 | Story André Damons | Photo Supplied
Dr Osayande Evbuomwan
Dr Osayande Evbuomwan, Senior Lecturer and Medical Specialist in the Department of Nuclear Medicine at the University of the Free State (UFS), with his certificate after winning the Society of Nuclear Medicine and Molecular Imaging (SNMMI) International Best Abstract Award for South Africa.

A research paper by a Senior Lecturer and Medical Specialist in the Department of Nuclear Medicine at the University of the Free State (UFS) has won the Society of Nuclear Medicine and Molecular Imaging (SNMMI) International Best Abstract Award for South Africa.

The abstract, by Dr Osayande Evbuomwan, was about evaluating the efficacy of a new nuclear medicine radiopharmaceutical in the identification of active disease in patients with rheumatoid arthritis. It was selected for this award by a special committee at the recently concluded SNMMI 2023 Annual Meeting, which took place between 24 and 27 June in Chicago, USA.

Dr Evbuomwan received the award at the Annual Meeting on 26 June.

“It is a good feeling, and I am proud of the UFS Department of Nuclear Medicine for pulling this off. It is another example that hard work pays,” he says.

Comparing this radiopharmaceutical to ultrasound

Dr Evbuomwan says the research that generated the award-winning abstract was aimed at finding out if the new nuclear medicine radiopharmaceutical for the identification of active disease in patients with rheumatoid arthritis can also offer prognostic information. The study concluded that this particular radiopharmaceutical (Tc – 99m glucosamine) is highly sensitive in identifying synovitis (inflammation of the membrane that protects joints), and is capable of offering prognostic information in patients with rheumatoid arthritis.

This is the first prospective study to assess the prognostic value of this radiopharmaceutical in patients with rheumatoid arthritis, Dr Evbuomwan says. He is currently working on comparisons of this radiopharmaceutical to ultrasound and clinical evaluation in the identification of active disease in patients with rheumatoid arthritis. He says there is also ongoing collaboration with the Rheumatology Division of the Internal Medicine Department, which has played a huge role in making this project fruitful.

“This award is an opportunity to put the department and university on the map, with world stage recognition. We believe that as the Nuclear Medicine Department continues to grow in human resources and equipment, the research output will also increase.”

Dr Gerrit Engelbrecht, Clinical Head of the Department of Nuclear Medicine at the UFS, says the whole department is very proud of Dr Evbuomwan’s accomplishments. “What makes his award even more remarkable is that he outperformed candidates from much larger, highly funded institutions,” he says.

This department announced last year the successful treatment outcome of a patient with metastatic castrate-resistant prostate cancer (MCRPC) – an advanced stage of prostate cancer – by using Lutetium 177 PSMA (Lu-177 PSMA) therapy. This was initially a case of advanced stage prostate cancer, which had failed first-line chemotherapy, leaving little or no other treatment options.

News Archive

UFS lecturer serves on National Forensic Oversight and Ethics Board
2015-02-13

Dr Karin Ehlers

Dr Karin Ehlers, lecturer in the Department of Genetics at the University of the Free State, was elected by the Minister of Police, Mr Nkosinathi Nhleko, to serve on the National Forensic Oversight and Ethics Board which will, among others, monitor the implementation of the provisions of the DNA Act.

Previously, when DNA evidence was collected at a crime scene, it was analysed only when requested by the prosecutor or investigator when they had found a suspect and needed confirmation. With the new DNA Act, all samples collected from violent crimes must be analysed. The profiles will be compared with a convicted offender database to see if some of the unsolved cases can be linked to these perpetrators. The reason for this is that many of these offenders are repeat offenders, and this process will increase the chances of solving cases successfully.

Serving on the Board, Dr Ehlers will also have the opportunity to contribute to proposals on:
- the improvement of practices regarding the overall operations of the National Forensic DNA Database (NFDD),
- the ethical, legal, and social implications of the use of forensic DNA profiles, and
- the training and the development of criteria for the use of familial searches.

Board members will also receive and assess complaints about alleged violations relating to the abuse of DNA samples and forensic DNA profiles and/or security breaches, and will report to complainants in respect thereof.

In 2014, when all citizens in South Africa were invited to apply for a position on the National Forensic Oversight and Ethics Board, Dr Ehlers submitted her application with a motivation on how she could contribute to the function of the Board. She is one of ten persons who were appointed to serve on the Board. “The reason I was successful was due to my involvement in the development of the UFS Forensic Sciences Programme,” Dr Ehlers said.

The capacity of the country was one of the challenges that had to be overcome for this Act to take effect. ”The UFS was able to address this problem, implementing degrees in Forensic Genetics and Forensic Sciences. With these programmes we made a real difference in the fight against crime. It is a real privilege to form part of this project,” said Dr Ehlers.

Dr Karin Ehlers serves on National Forensic Oversight and Ethics Board (read the full story)

 

For more information or enquiries contact news@ufs.ac.za

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept